US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Harvard Bioscience Inc (HBIO)
Harvard Bioscience Inc (HBIO) ニュース

HBIO

Harvard Bioscience (HBIO)

Harvard Bioscience Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:HBIO

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/17	05 : 05	GlobeNewswire Inc.	Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference	NASDAQ:HBIO	Harvard Bioscience Inc
2024/05/15	06 : 20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HBIO	Harvard Bioscience Inc
2024/05/08	06 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:HBIO	Harvard Bioscience Inc
2024/05/07	20 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HBIO	Harvard Bioscience Inc
2024/05/07	20 : 00	GlobeNewswire Inc.	Harvard Bioscience Announces First Quarter 2024 Financial Results	NASDAQ:HBIO	Harvard Bioscience Inc
2024/04/29	21 : 45	GlobeNewswire Inc.	Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET	NASDAQ:HBIO	Harvard Bioscience Inc
2024/04/09	22 : 00	GlobeNewswire Inc.	Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth	NASDAQ:HBIO	Harvard Bioscience Inc
2024/03/11	21 : 00	GlobeNewswire Inc.	Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference	NASDAQ:HBIO	Harvard Bioscience Inc
2024/03/08	07 : 00	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:HBIO	Harvard Bioscience Inc
2024/03/08	06 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HBIO	Harvard Bioscience Inc
2024/03/08	06 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HBIO	Harvard Bioscience Inc
2024/03/07	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HBIO	Harvard Bioscience Inc
2024/03/07	21 : 00	GlobeNewswire Inc.	Harvard Bioscience Announces Fourth Quarter 2023 Financial Results	NASDAQ:HBIO	Harvard Bioscience Inc
2024/03/06	22 : 30	GlobeNewswire Inc.	Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting	NASDAQ:HBIO	Harvard Bioscience Inc
2024/02/28	07 : 10	GlobeNewswire Inc.	Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET	NASDAQ:HBIO	Harvard Bioscience Inc
2024/02/15	06 : 05	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:HBIO	Harvard Bioscience Inc
2024/02/14	23 : 00	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:HBIO	Harvard Bioscience Inc
2024/02/14	22 : 46	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:HBIO	Harvard Bioscience Inc
2024/01/06	07 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HBIO	Harvard Bioscience Inc
2024/01/04	07 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HBIO	Harvard Bioscience Inc
2024/01/04	07 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HBIO	Harvard Bioscience Inc
2023/11/21	06 : 40	GlobeNewswire Inc.	Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023	NASDAQ:HBIO	Harvard Bioscience Inc
2023/11/10	06 : 30	GlobeNewswire Inc.	Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023	NASDAQ:HBIO	Harvard Bioscience Inc
2023/11/08	06 : 45	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:HBIO	Harvard Bioscience Inc
2023/11/07	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HBIO	Harvard Bioscience Inc
2023/11/07	21 : 00	GlobeNewswire Inc.	Harvard Bioscience Announces Third Quarter 2023 Financial Results	NASDAQ:HBIO	Harvard Bioscience Inc
2023/11/07	06 : 30	GlobeNewswire Inc.	Harvard Bioscience to Showcase Latest Innovations in Preclinical and Organoid Research at Society for Neuroscience Conference on November 12-15, 2023	NASDAQ:HBIO	Harvard Bioscience Inc
2023/10/30	22 : 00	GlobeNewswire Inc.	Harvard Bioscience Schedules Third Quarter 2023 Earnings Conference Call for November 7, 2023 at 8:00 AM ET	NASDAQ:HBIO	Harvard Bioscience Inc
2023/09/18	21 : 57	GlobeNewswire Inc.	Harvard Bioscience and Etisense Announce Agreement for Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research	NASDAQ:HBIO	Harvard Bioscience Inc
2023/08/22	05 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HBIO	Harvard Bioscience Inc

Showing the most relevant articles for your search:NASDAQ:HBIO

1 2 3 4 5 6 7 8 9 10 次へ >>

Consulting Automotive Ae...

Dermata Therapeutics

X1 Entertainment (PK)

UBS LUXFnd Solut BBG Bar...

Vontobel Financial Produ...

US Treasury Bond 30y ETN...

Pantheon Infrastructure

Accelleron Industries (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約